Cargando…

Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis

BACKGROUND: Prolactin (PRL) reduces joint inflammation, pannus formation, and bone destruction in rats with polyarticular adjuvant-induced arthritis (AIA). Here, we investigate the mechanism of PRL protection against bone loss in AIA and in monoarticular AIA (MAIA). METHODS: Joint inflammation, trab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ledesma-Colunga, Maria G., Adán, Norma, Ortiz, Georgina, Solís-Gutiérrez, Mariana, López-Barrera, Fernando, Martínez de la Escalera, Gonzalo, Clapp, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433139/ https://www.ncbi.nlm.nih.gov/pubmed/28506283 http://dx.doi.org/10.1186/s13075-017-1290-4

Ejemplares similares

Dual Roles of Prolactin and Vasoinhibin in Inflammatory Arthritis
por: Clapp, Carmen, et al.
Publicado: (2022)

MON-486 Prolactin Reduces the Hyperoxia-Induced Inhibition of Retinal Neovascularization in Newborn Mice
por: Vazquez-Membrillo, Miguel, et al.
Publicado: (2019)

FRI295 Prolactin Exerts Anti- And Pro-inflammatory Actions In Joint Tissues That Are Cytokine-Dependent
por: García Rodrigo, José Fernando, et al.
Publicado: (2023)

Principles of the prolactin/vasoinhibin axis
por: Triebel, Jakob, et al.
Publicado: (2015)

Remarks on the Prolactin Hypothesis of Peripartum Cardiomyopathy
por: Triebel, Jakob, et al.
Publicado: (2017)

Global Deletion of the Prolactin Receptor Aggravates Streptozotocin-Induced Diabetes in Mice
por: Ramirez-Hernandez, Gabriela, et al.
Publicado: (2021)

A New Experimental Tool Toward Understanding the Regulation of Human Prolactin Secretion and Functions
por: Martínez de la Escalera, Gonzalo, et al.
Publicado: (2022)

The beneficial metabolic actions of prolactin
por: Macotela, Yazmín, et al.
Publicado: (2022)

A Dysregulation of the Prolactin/Vasoinhibin Axis Appears to Contribute to Preeclampsia
por: Lenke, Livia, et al.
Publicado: (2020)

Commentary: Prolactin Alters Blood Pressure by Modulating the Activity of Endothelial Nitric Oxide Synthase
por: Triebel, Jakob, et al.
Publicado: (2017)

From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis
por: Triebel, Jakob, et al.
Publicado: (2017)

Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases
por: Triebel, Jakob, et al.
Publicado: (2017)

The Diversity of Gut Microbiota at Weaning Is Altered in Prolactin Receptor-Null Mice
por: Luzardo-Ocampo, Ivan, et al.
Publicado: (2023)

High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular Vasoinhibins
por: Arnold, Edith, et al.
Publicado: (2010)

Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy
por: Nuñez-Amaro, Carlos D., et al.
Publicado: (2020)

The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling
por: Robles, Juan Pablo, et al.
Publicado: (2022)

Extracellular Vesicles Derived From Murine Cementoblasts Possess the Potential to Increase Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclastogenesis
por: Sato, Rei, et al.
Publicado: (2022)

Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress
por: Arredondo Zamarripa, David, et al.
Publicado: (2014)

Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited
por: Triebel, Jakob, et al.
Publicado: (2022)

Prolactin protects retinal pigment epithelium by inhibiting sirtuin 2-dependent cell death
por: Meléndez García, Rodrigo, et al.
Publicado: (2016)

Carnosol inhibits osteoclastogenesis in vivo and in vitro by blocking the RANKL-induced NF-κB signaling pathway
por: Cai, Pan, et al.
Publicado: (2022)

NF-κB-Mediated Regulation of Osteoclastogenesis
por: Boyce, Brendan F., et al.
Publicado: (2015)

Prolactin Receptor (PRLR) Isoform Expression in the Murine Oviduct
por: Radecki, Kelly C, et al.
Publicado: (2021)

IL-35 inhibits human osteoclastogenesis from monocytes induced by receptor-activator of NF-κB ligand
por: Yago, Toru, et al.
Publicado: (2018)

Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors
por: Rinotas, Vagelis, et al.
Publicado: (2023)

Receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds
por: Qu, Zechao, et al.
Publicado: (2022)

Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor
por: Borcherding, Dana C., et al.
Publicado: (2021)

Palatal fibroblasts reduce osteoclastogenesis in murine bone marrow cultures
por: Voisin, Victoria, et al.
Publicado: (2016)

Liquid PRF Reduces the Inflammatory Response and Osteoclastogenesis in Murine Macrophages
por: Kargarpour, Zahra, et al.
Publicado: (2021)

Isopsoralen suppresses receptor activator of nuclear factor kappa-β ligand-induced osteoclastogenesis by inhibiting the NF-κB signaling
por: Zhan, Wanda, et al.
Publicado: (2023)

Differential effects of growth hormone and prolactin on murine T cell development and function
Publicado: (1993)

The effects of prolactin receptor blockade in a murine endometriosis interna model
por: Otto, Christiane, et al.
Publicado: (2022)

Pathway Analysis of MicroRNA Expression Profile during Murine Osteoclastogenesis
por: Franceschetti, Tiziana, et al.
Publicado: (2014)

The utility of prolactin serial sampling and the best prolactin cut-offs associated with persistent hyperprolactinemia
por: Cidade-Rodrigues, Catarina, et al.
Publicado: (2021)

Guaiacol suppresses osteoclastogenesis by blocking interactions of RANK with TRAF6 and C‐Src and inhibiting NF‐κB, MAPK and AKT pathways
por: Zhi, Xin, et al.
Publicado: (2020)

A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways
por: Liu, Ying, et al.
Publicado: (2021)

Prolactin Expression in the Baboon (Papio hamadryas) Eye
por: Garza-Rodríguez, María Lourdes, et al.
Publicado: (2022)

Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis
por: Morita, Takayoshi, et al.
Publicado: (2019)

N-Terminal Prolactin-Derived Fragments, Vasoinhibins, Are Proapoptoptic and Antiproliferative in the Anterior Pituitary
por: Ferraris, Jimena, et al.
Publicado: (2011)

The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis
por: Novack, Deborah Veis, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_l577gok5tad21gv9i90sdlk698